Maternal and fetal/neonatal pharmacokinetics and - dynamics of corticosteroids during pregnancy as treatment for fetal lung maturatio
- Conditions
- (Imminent) preterm birth
- Registration Number
- NL-OMON25709
- Lead Sponsor
- Erasmus MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
1)Older than 18 years of age.
2)Admitted at the Department of Obstetrics at Erasmus MC – Sophia for suspicion of preterm birth with a gestational age of 23+5 weeks until 33+6 weeks.
3)Understanding of Dutch in speaking and reading.
4)Written informed consent.
A potential subject who meets any of the following criteria will be excluded from participation in this study:
1)Women unable or unwilling to agree with the procedures.
2)Women unable or unwilling to give written informed consent.
3)Women with acute obstetric complications requiring immediate delivery at time of admission.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To examine the pharmacokinetics in maternal blood of standard regimen
- Secondary Outcome Measures
Name Time Method To examine the relation between diverse maternal factors and the pharmacokinetics of the primary objective.